Clinical Trials in Pittsburgh

Showing 4981-5000 of 21,047 trials

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

NCT06503367

The goal of this observational study is to understand how young children with LAMA2-related dystrophy move and change over time. We will also learn about how this condition impacts other body systems. Participants will undergo: * Neuromuscular assessments * Blood collections * Swallowing and breathing assessments * Questionnaires

LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)

Nationwide Children's Hospital44 participantsStarted May 2025

Los Angeles, California, United States • Stanford, California, United States • Chicago, Illinois, United States +11 more locations

RECRUITINGNA< 1 mile

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

NCT06386029

The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do the families find the Power Down an acceptable intervention to address their child's difficulties settling down to fall asleep?

AutismSleep Disturbance

University of Pittsburgh10 participantsStarted Jul 2025

Pittsburgh, Pennsylvania, United States

Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

Find Trials by Condition in Pittsburgh

Spinal Cord Stimulation for Restoration of Arm and Hand Function in People With Subcortical Stroke

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD Emphysema

A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis

COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations

Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies

A Study to Investigate Safety and Tolerability of NDX-3315 and NDX-3324 in Healthy Participants and Patients With Eosinophilic Esophagitis

Decisions About Cancer Screening in Alzheimer's Disease

Cisplatin Disposition and Kidney Injury

Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk

EMPOWER AUD Pivotal Trial

A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors